ESC 365 - One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – PRO.

ACVC Premium Access

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – PRO.

Session: The 2020 NSTE - ACS guidelines in practice – the pros and cons

Topic: Acute Coronary Syndromes

Speaker: Professor R. Lopes (Durham, US)

Event: ACVC 2021

Congress Presentation

About the speaker

Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)

20 presentations

0 follower

5 more presentations in this session

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - PRO.

Speaker: Professor C. Mueller (Basel, CH)

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - CON.

Speaker: Assistant Professor E. Giannitsis (Heidelberg, DE)

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - Discussion.

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – CON.

Speaker: Professor G. Montalescot (Paris, FR)

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – Discussion.

Access the full session

The 2020 NSTE - ACS guidelines in practice – the pros and cons

Speakers: Professor R. Lopes, Professor C. Mueller, Assistant Professor E. Giannitsis, Professor G. Montalescot

About the event

ACVC 2021

13 March - 14 March 2021

Sessions Presentations

Congress

Related content

Open Access

Management of ASCVD risk in apparently healthy people.

30 August 2021

Open Access

Introduction, novel concepts in the 2021 ESC Prevention Guideline.

30 August 2021

Open Access

Advanced and acute heart failure.

27 August 2021

ESC 365 is supported by